NCT01634373 Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Status COMPLETED Phase PHASE1
NCT01629355 Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder Status COMPLETED Phase N/A
NCT01626885 A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT01626872 Long-Term Study of MP-214 in Patients With Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT01626859 A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT01626456 A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) Status COMPLETED Phase PHASE3
NCT01625897 A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT01625000 Safety and Efficacy of MP-214 in Patients With Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT01623726 Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia Status WITHDRAWN Phase PHASE2
NCT01623713 Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia Status COMPLETED Phase PHASE2
NCT01620086 Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia Status COMPLETED Phase NA
NCT01617200 Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) Status COMPLETED Phase PHASE3
NCT01617187 A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) Status COMPLETED Phase PHASE3
NCT01615185 A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia Status TERMINATED Phase PHASE4
NCT01614912 Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01614899 A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia Status COMPLETED Phase PHASE3